This survey is a collaborative effort by ICUDDR, NECPAM and ISAM. Together, we are trying to assess the impact recent reductions in funding have had to the workforce of fields dealing with substance use related issues.
CSUCH’s data visualisation tool can be used to estimate substance use trends across the country. The data helps inform programs, practices, and research to protect communities, save lives, and improve the well-being of people in Canada.
Spotlight: Top 3 causes of death due to substance use in Canada
More than 200 people died each day due to substance use (SU) in 2020 (the latest year for which data are available). That works out to 73,994 deaths that year. The average age of death due to SU was 45 years. Tobacco use caused 63% (46,366) of SU-related deaths, followed by alcohol at 23%...
Addiction and obesity share similar neurological pathways, both linked to compulsive behaviors and the brain's reward system. Research has highlighted the potential of GLP-1 receptor agonists, originally developed for diabetes, to help manage both appetite and addictive cravings. These medications, such as semaglutide, may regulate addictive behaviors by influencing reward circuits in the brain. However, they come with potential side effects, and their long-term effects are still under investigation.
In addition, a new compound, 5-Methoxy-2-aminoindane (MEAI), is being researched for its...
This week, we say goodbye to our dear friend and mentor, Jeff Lee, the founding Executive Director of ISSUP. Jeff was a steadfast advocate for the professionalization of prevention, insisting that those working in this field should be appropriately specialized. He often reminded us that while generalists and treatment specialists are well-meaning and deeply embedded within their communities, they are not always best placed to develop and implement evidence-based prevention systems. Jeff emphasized that prevention must be treated as a distinct science—one that is grounded in rigorous research...
El Equipo de los Capítulos Nacionales celebró una reunión virtual fundamental de 2 días del 10 al 11 de diciembre de 2024 para evaluar el modelo operativo actual de los Capítulos Nacionales e identificar oportunidades de mejora y crecimiento. La reunión fue denominada una "Reunión de Visión" para reflejar la agenda central: la elaboración de un plan con visión de futuro para los Capítulos Nacionales de ISSUP.
The Global Recovery Network is committed to providing valuable and relevant content for our community.
To ensure our upcoming webinar series aligns with the needs and interests of our audience, we have developed this survey with U.S. based Faces and Voices of Recovery to determine which topics may be of most relevance. Our goal is to offer webinars that not only inform but also develop and build skills that support recovery, advocacy, and professional growth.
Your feedback is crucial in helping us design a webinar series that resonates with and benefits you.
Don't miss our latest newsletter for details of recent meetings and activities in Latin America and Africa. This issue also includes information on how to gain advanced clinical skills with the UTC16 Self Led Course.
A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2024 comprises several elements tailored to different audiences.
European Monitoring Centre for Drugs and Drug Addiction and Europol (2024), EU Drug Market: Drivers and facilitators, https://www.emcdda.europa.eu/publications/eu-drug-markets/drivers-and-f…
EU Drug Market: Drivers and facilitators provides an overview of the key factors influencing the operation of the markets for illicit drugs in the European Union. It considers the changes and developments happening in the wider environment in which the illicit drug market is embedded (drivers), and the people or processes (facilitators) that make it easier to commit drug-related criminality or avoid detection. The focus of the report is on identifying key issues and presenting recommendations for action at EU and Member State level.
European Monitoring Centre for Drugs and Drug Addiction (2024), European Drug Report 2024: Trends and Developments, https://www.emcdda.europa.eu/publications/european-drug-report/2024_en
El Informe Europeo sobre Drogas 2024: Tendencias y Evolución presenta el último análisis del OEDT sobre la situación de las drogas en Europa. Centrándose en el consumo de drogas ilícitas, los daños conexos y la oferta de drogas, el informe proporciona un conjunto exhaustivo de datos nacionales sobre estos temas, así como sobre el tratamiento especializado de las drogas y las intervenciones clave de reducción de daños.
El objetivo del informe es ofrecer una visión general y un resumen de la situación europea en materia de drogas hasta finales de 2023.
Stimulants are a class of drugs that act on the central nervous system, increasing alertness, energy, and attention while elevating mood. They achieve these effects by enhancing the activity of neurotransmitters such as dopamine and norepinephrine in the brain.
Many stimulant-related hazards are linked to intensive, high-dose, or long-term usage. The mode of administration plays a significant moderating role; injecting stimulants and smoking crack cocaine or methamphetamine have been specifically associated with more problematic use behaviours. Even people who use stimulants sporadically or...